BIONECT CREAM, 25G TUBE

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04 report with the FDA on 2014-09-02 for BIONECT CREAM, 25G TUBE manufactured by Innocutis.

Event Text Entries

[4746026] This spontaneous report was received from a consumer via phone on (b)(6) 2013. The consumer reports that he has a dry skin condition on his scalp and that a dermatologist advised him to use the product. He finds that when he uses the product, his scalp becomes very red. He contacted the dermatologist, who advised him to keep using the product, and that the redness "should calm down. " caller wishes to know if this is advisable, as the redness seems to progressively worsen. It was explained to the caller that increased redness and soreness are not expected effects with product use. It was recommended that he discontinue use of the product, and consult with his dermatologist about the symptoms he is having, and request further guidance from the doctor.
Patient Sequence No: 1, Text Type: D, B5


[12314661] The information contained in this report is based on self-reported statements provided to the manufacturer during a telephone interview. These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the report clinical effects are causally related or associated with an exposure to the product identified in the telephone interview. The information provided in this report has not been medically verified via confirmation with the patient's physicians or by the provision of patient medical records. When considering the body of regulatory data and post-marketing data as well as the wright of scientific peer reviewed evidence on topically applied hyaluronate containing product such a causal relationship between the use of this type of device and the development of the adverse effects reported in this case cannot be definitively established. When evaluating a patient for a potential hypersensitivity (allergic) reaction, a clinical practitioner must consider several potential environmental etiologies as well as any goods, beverages, medications, or dietary supplements the patient had been taking just prior to the onset of symptoms. Definitive causality cannot be applied to any one compound or agent without verification.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3005536974-2014-00002
MDR Report Key4088166
Report Source04
Date Received2014-09-02
Date of Report2014-08-13
Date of Event2013-01-29
Date Mfgr Received2013-01-29
Device Manufacturer Date2011-11-01
Date Added to Maude2014-09-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactART WAITE
Manufacturer Street171 CHURCH ST. STE 140
Manufacturer CityCHARLESTON SC 29401
Manufacturer CountryUS
Manufacturer Postal29401
Manufacturer Phone8439658333
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBIONECT CREAM, 25G TUBE
Generic NameHYALURONATE SODIUM
Product CodeMGQ
Date Received2014-09-02
Model NumberNA
Lot Number0164
ID Number68712-007-02
Device Expiration Date2013-11-01
OperatorLAY USER/PATIENT
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerINNOCUTIS
Manufacturer Address171 CHURCH ST. STE 140 CHARLESTON SC 29401 US 29401


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2014-09-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.